Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00082862
Status:
UNKNOWN
Last Update Posted:
2012-02-13
First Post:
2004-05-14
Brief Title:
Cisplatin Metronomic Low-Dose Interferon Alfa Gemcitabine and Fever-Range Whole-Body Hyperthermia in Treating Patients With Inoperable or Metastatic Pancreatic Cancer
Sponsor:
The University of Texas Health Science Center Houston
Organization:
National Cancer Institute NCI
Organization Data
Organization:
National Cancer Institute NCI
Class:
NIH
Study ID:
CDR0000360863
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
The University of Texas Health Science Center Houston
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Joan MC Bull
Old Organization:
University of Texas Health Science Center at Houston